Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Immucell (ICCC) Raw Materials (2018 - 2025)

Immucell's Raw Materials history spans 8 years, with the latest figure at $1.7 million for Q4 2025.

  • For Q4 2025, Raw Materials rose 21.72% year-over-year to $1.7 million; the TTM value through Dec 2025 reached $1.7 million, up 21.72%, while the annual FY2025 figure was $1.7 million, 21.72% up from the prior year.
  • Raw Materials reached $1.7 million in Q4 2025 per ICCC's latest filing, down from $1.9 million in the prior quarter.
  • In the past five years, Raw Materials ranged from a high of $2.4 million in Q4 2022 to a low of $660547.0 in Q1 2021.
  • Average Raw Materials over 5 years is $1.6 million, with a median of $1.6 million recorded in 2025.
  • Peak YoY movement for Raw Materials: crashed 44.29% in 2024, then soared 42.54% in 2025.
  • A 5-year view of Raw Materials shows it stood at $660547.0 in 2021, then surged by 266.36% to $2.4 million in 2022, then tumbled by 34.13% to $1.6 million in 2023, then decreased by 14.92% to $1.4 million in 2024, then grew by 21.72% to $1.7 million in 2025.
  • Per Business Quant, the three most recent readings for ICCC's Raw Materials are $1.7 million (Q4 2025), $1.9 million (Q3 2025), and $1.5 million (Q2 2025).